Zimmer Biomet Holdings Inc (N:ZBH)

Business Focus: Medical Equipment, Supplies & Distribution

Feb 06, 2019 07:45 ET
Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Brands, Radius Health, Kaman, and FARO Technologies — What Drives Growth in Today's Competitive Landsc
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Edwards Lifesciences Corporation (NYSE:EW), Zimmer Biomet Holdings, Inc....
Feb 01, 2019 05:00 ET
Zimmer Biomet Announces Fourth Quarter and Full-Year 2018 Financial Results
WARSAW, Ind., Feb. 1, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and full year ended December 31, 2018.  The Company reported fourth quarter net sales of $2.071 billion, an increase of 0.1% over the prior year period, and an increase of 1.6% on a constant currency basis.  Diluted loss per share for the fourth quarter was $4.42.  The Company's diluted loss per share included goodwill impairment charges of $4.78 per share and legal charges of $0.59 per share primarily related to a previously disclosed patent litigation...
Jan 29, 2019 16:00 ET
Zimmer Biomet Holdings to Present at 8th Annual SVB Leerink Global Healthcare Conference
WARSAW, Ind., Jan. 29, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the 8th Annual SVB Leerink Global Healthcare Conference at the Lotte New York Palace in New York, New York. Cole Lannum, Senior Vice President of Investor Relations, will present for the Company on February 27, 2019 at 11:30 a.m. Eastern Time. ...
Jan 25, 2019 08:02 ET
Zimmer Biomet Receives FDA Clearance for ROSA® Knee System for Robotically-Assisted Surgeries
WARSAW, Ind., Jan. 25, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) clearance of the ROSA® Knee System for robotically-assisted total knee replacement surgeries. ROSA Knee features 3D pre-operative planning tools and real-time, intraoperative data on soft-tissue and bone anatomy designed to improve bone cut accuracy and range of motion gap analysis to potentially improve flexion and restoration of natural joint movement. ...
Dec 18, 2018 16:00 ET
Zimmer Biomet to Present at 37th Annual J.P. Morgan Healthcare Conference
WARSAW, Ind., Dec. 18, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 8, 2019 at 10:00 a.m. Pacific Time.  ...
Dec 17, 2018 16:00 ET
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Fourth Quarter 2018 Results
WARSAW, Ind., Dec. 17, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter sales and earnings conference call will be broadcast over the Internet on Friday, February 1, 2019, at 8:30 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 6:00 a.m. Eastern Time the morning of the conference call....
Dec 12, 2018 06:00 ET
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2018
WARSAW, Ind., Dec. 12, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2018. ...
Dec 10, 2018 08:25 ET
Detailed Research: Economic Perspectives on Xcel Energy, Franklin Resources, Axalta Coating, Restaurant Brands International, Zimmer Biomet, and Ford Motor — What Drives Growth in Today's Competitive
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Xcel Energy Inc. (NASDAQ:XEL), Franklin Resources, Inc. (NYSE:BEN),...
Nov 01, 2018 08:20 ET
Consolidated Research: 2018 Summary Expectations for Dr. Reddy's Laboratories, Union Pacific, Zimmer Biomet, Varian Medical, Sonic Automotive, and Axalta Coating — Fundamental Analysis, Key Performanc
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Dr. Reddy's Laboratories Ltd (NYSE:RDY), Union Pacific Corporation...
Oct 26, 2018 06:00 ET
Zimmer Biomet Announces Third Quarter 2018 Financial Results
WARSAW, Ind., Oct. 26, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2018.  The Company reported third quarter net sales of $1.837 billion, an increase of 1.3% over the prior year period, and an increase of 2.3% on a constant currency basis.  Diluted earnings per share for the third quarter were $0.79, an increase of 65% over the prior year period.  Third quarter adjusted diluted earnings per share were $1.63, a decrease of 5% from the prior year period. ...
Oct 24, 2018 17:00 ET
The Shuman Law Firm Investigates Zimmer Biomet Holdings, Inc.
The Shuman Law Firm announces that it is investigating potential shareholder claims against certain officers and directors of Zimmer Biomet Holdings, Inc. (“ZBH” or the “Company”) (Nasdaq:
Oct 13, 2018 10:29 ET
Johnson Fistel Announces Investigations of Zimmer Biomet Holdings, Inc., Acadia Healthcare Company, and Floor & Decor Holdings, Inc.; Investors Encouraged to Contact Firm
SAN DIEGO, Oct. 13, 2018 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Zimmer Biomet Holdings, Inc., Acadia Healthcare Company, Inc., and Floor & Decor Holdings, Inc., as detailed below:...
Oct 01, 2018 17:00 ET
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Third Quarter 2018 Results
WARSAW, Ind., Oct. 1, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter sales and earnings conference call will be broadcast over the Internet on Friday, October 26, 2018, at 8:30 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 6 a.m. Eastern Time the morning of the conference call....
Sep 13, 2018 07:00 ET
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2018
WARSAW, Ind., Sept. 13, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2018. ...
Sep 10, 2018 07:00 ET
Zimmer Biomet Holdings to Present at Morgan Stanley 16th Annual Global Healthcare Conference
WARSAW, Ind., Sept. 10, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt hotel in New York.  Zimmer Biomet will present on Wednesday, September 12, 2018 at 10:30 a.m. Eastern Time....
Aug 10, 2018 08:30 ET
New Research Coverage Highlights EOG Resources, Zimmer Biomet, MGIC Investment, EPR Properties, Guess?, and Mednax — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EOG Resources, Inc. (NYSE:EOG), Zimmer Biomet Holdings, Inc. (NYSE:ZBH),...
Aug 03, 2018 07:00 ET
Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado and Syed Jafry to Board of Directors
WARSAW, Ind., Aug. 3, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Maria Teresa (Tessa) Hilado, former Executive Vice President and Chief Financial Officer of Allergan PLC, and Syed Jafry, Senior Vice President and President, Asia Pacific, EMEA and Emerging Markets, Thermo Fisher Scientific Inc., have been appointed to the Company's Board of Directors, effective immediately. ...
Jul 27, 2018 06:00 ET
Zimmer Biomet Announces Second Quarter 2018 Financial Results
WARSAW, Ind., July 27, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2018.  The Company reported second quarter net sales of $2.008 billion, an increase of 3.0% over the prior year period, and an increase of 1.0% on a constant currency basis.  Diluted earnings per share for the second quarter were $0.90, flat when compared to the prior year period.  Second quarter adjusted diluted earnings per share were $1.92, a decrease of 7.7% from the prior year period. ...
Jun 20, 2018 17:00 ET
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Second Quarter 2018 Results
WARSAW, Ind., June 20, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter sales and earnings conference call will be broadcast over the Internet on Friday, July 27, 2018, at 8:30 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 6 a.m. Eastern Time the morning of the conference call....
Jun 14, 2018 17:00 ET
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2018
WARSAW, Ind., June 14, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2018. ...
Jun 07, 2018 17:00 ET
Zimmer Biomet to Present at Goldman Sachs 39th Annual Global Healthcare Conference
WARSAW, Ind., June 7, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Goldman Sachs 39th Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, Calif. on Wednesday, June 13, 2018 at 10:40 a.m. Pacific Time. ...
May 21, 2018 07:00 ET
Zimmer Biomet Announces Call for Applications for the 2018 Connected Health Innovation Award
WARSAW, Ind., May 21, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a call for applications for its second Connected Health Innovation Award. The Company is accepting applications from individuals, groups and organizations — including academia and industry — from all countries within Europe, the Middle East and Africa (EMEA) region. The award honors digital innovations that help solve unmet needs in the treatment of musculoskeletal and orthopaedic conditions. The winner will receive a €25,000 prize, an op...
May 10, 2018 07:45 ET
Recent Analysis Shows Amkor Technology, Nielsen Holdings Plc, Dean Foods, Citizens Financial Group, The Bank of New York Mellon, and Zimmer Biomet Market Influences — Renewed Outlook, Key Drivers of G
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amkor Technology, Inc. (NASDAQ:AMKR), Nielsen Holdings Plc (NYSE:NLSN),...
May 07, 2018 17:00 ET
Zimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
WARSAW, Ind., May 7, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal care, today announced that it will be presenting at the Bank of America Merrill Lynch 2018 Health Care Conference at the Encore at the Wynn in Las Vegas, Nevada on Wednesday, May 16, at 9:20 a.m. Pacific Time....
May 03, 2018 17:00 ET
Zimmer Biomet Holdings to Present at Deutsche Bank 43rd Annual Health Care Conference
WARSAW, Ind., May 3, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Deutsche Bank 43rd Annual Health Care Conference at the InterContinental Hotel in Boston, Massachusetts on Tuesday, May 8, 2018.  Zimmer Biomet will present at 11:20 a.m. Eastern Time....
Apr 30, 2018 17:00 ET
Zimmer Biomet Partners with Faith In Practice to Improve Access to Musculoskeletal Care in Guatemala
WARSAW, Ind., April 30, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has entered into a partnership agreement with Faith In Practice, a Houston-based non-profit organization that provides surgical, medical, dental and educational programs in Guatemala. Under the partnership, Zimmer Biomet will donate instrument sets and provide implants for Faith In Practice to place in inventory with the goal of improving access to total knee arthroplasty procedures for patients in underserved communities. ...
Apr 26, 2018 06:00 ET
Zimmer Biomet Announces First Quarter 2018 Financial Results
WARSAW, Ind., April 26, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2018.  The Company reported first quarter net sales of $2.018 billion, an increase of 2.3% over the prior year period, and a decrease of 1.5% on a constant currency basis.  Diluted earnings per share for the first quarter were $0.85, a decrease of 42.2% from the prior year period.  First quarter adjusted diluted earnings per share were $1.91, a decrease of 10.3% from the prior year period. ...
Apr 18, 2018 17:00 ET
Oregon Surgical Institute to Implement Zimmer Biomet Signature Solutions Outpatient Program
WARSAW, Ind., April 18, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced an agreement with Oregon Surgical Institute, a new ambulatory surgery center (ASC) in Beaverton, Ore., to implement the Zimmer Biomet Signature Solutions Outpatient Program. Oregon Surgical Institute, a joint venture between Regent Surgical Health and West End Surgical, LLC, is designed specifically to treat complex cases and procedures focused on total joint replacement and spine disorders. ...
Apr 16, 2018 17:00 ET
Zimmer Biomet Announces FDA Clearance and First Surgical Case of the Persona® Trabecular Metal™ Tibia
WARSAW, Ind., April 16, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the completion of the first surgical case utilizing its Persona® Trabecular Metal™ (TM) Tibia by Dr. Richard Moore, Boise, Idaho on March 20, 2018. The Persona Trabecular Metal Tibia received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2018 and CE Mark approval in April 2018. The Persona TM Tibia is an integral component of the Company's portfolio of cementless total knee arthroplasty (TKA) solutions.  ...
Apr 02, 2018 17:00 ET
Zimmer Biomet Announces FDA Clearance of the Comprehensive® Augmented Baseplate for Shoulder Reconstruction
WARSAW, Ind., April 2, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the completion of the first surgical case utilizing its Comprehensive® Augmented Baseplate, which received FDA clearance on January 3, 2018. The case was performed by John W. Sperling, M.D., an orthopaedic surgeon at Mayo Clinic, who specializes in shoulder surgery. The Comprehensive Augmented Baseplate complements the Company's Comprehensive® Reverse Shoulder System by offering an alternative to bone grafting and eccentric reaming for p...
Mar 28, 2018 17:00 ET
Zimmer Biomet Spine Announces Mobi-C® Cervical Disc Seven-Year Follow-Up Data Published in International Journal of Spine Surgery
WARSAW, Ind., March 28, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the full seven-year follow-up data from a study evaluating the Company's Mobi-C® Cervical Disc for total disc replacement has been published in the peer-reviewed International Journal of Spine Surgery, the official scientific journal of the International Society for the Advancement of Spine Surgery (ISASS). The Mobi-C Cervical Disc is a leading option for cervical total disc replacement (cTDR) that is designed to maintain pati...
Mar 26, 2018 17:00 ET
Zimmer Biomet Joins U.S. Department of Energy's Better Buildings, Better Plants Program
WARSAW, Ind., March 26, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced its participation in the U.S. Department of Energy's (DOE) Better Buildings, Better Plants program. Zimmer Biomet entered into the voluntary agreement with the DOE in January as part of the Company's ongoing efforts to reduce its carbon footprint at locations across the United States and Puerto Rico. ...
Mar 22, 2018 17:00 ET
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of First Quarter 2018 Results
WARSAW, Ind., March 22, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter sales and earnings conference call will be broadcast over the Internet on Thursday, April 26, 2018, at 8:30 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 6 a.m. Eastern Time the morning of the conference call....
Mar 19, 2018 16:30 ET
Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations
WARSAW, Ind., March 19, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Coleman (Cole) N. Lannum has been appointed Senior Vice President of Investor Relations, reporting directly to the Company's President and CEO, Bryan C. Hanson. ...
Mar 12, 2018 17:00 ET
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2018
WARSAW, Ind., March 12, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2018. ...
Mar 08, 2018 17:00 ET
Zimmer Biomet Prices Offering of Senior Notes
WARSAW, Ind., March 8, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced that it has priced an offering of $450 million principal amount of its floating rate senior unsecured notes due 2021 and $300 million principal amount of its 3.700% senior unsecured notes due 2023. ...
Mar 08, 2018 07:40 ET
Detailed Research: Economic Perspectives on Cardtronics, Helix Energy, Plains Group Holdings, Vista Outdoor, Intrexon, and Zimmer Biomet — What Drives Growth in Today's Competitive Landscape
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cardtronics PLC (NASDAQ:CATM), Helix Energy Solutions...
Mar 06, 2018 06:30 ET
Zimmer Biomet Exhibits Product and Service Innovations at AAOS 2018
WARSAW, Ind., March 6, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it will be showcasing its latest commercial offerings and previewing its next generation of technological innovations at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 6-10 in New Orleans, Louisiana. ...
Feb 08, 2018 16:00 ET
Zimmer Biomet's Rapid Recovery Program Marks Two Decades of Success in Europe
WARSAW, Ind., Feb. 8, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is marking the 20th anniversary of Rapid Recovery, an evidence-based program optimizing all aspects of a patient's care pathway and surgical experience. Zimmer Biomet pioneered Rapid Recovery in 1997 to complement its commercial product offerings and help healthcare providers improve the quality and cost-efficiency of patient care. Zimmer Biomet's Rapid Recovery program combines the principles of fast-track surgery with evidence-based approaches to proce...
Jan 30, 2018 06:45 ET
Zimmer Biomet Holdings, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / January 30, 2018 / Zimmer Biomet Holdings, Inc. (NYSE: ZBH) will be discussing their earnings results in their Q4 Earnings Call to be held on January 30, 2018 at 8:00 AM Eastern Time.
Jan 30, 2018 06:00 ET
Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results
WARSAW, Ind., Jan. 30, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and full year ended December 31, 2017.  The Company reported fourth quarter net sales of $2.074 billion, an increase of 3.0% over the prior year period, and an increase of 1.5% on a constant currency basis.  Diluted earnings per share for the fourth quarter were $6.16, and include a one-time tax benefit of approximately $6.40 resulting from the recently enacted U.S. tax reform legislation.  Fourth quarter adjusted diluted earnings per share were $2.10,...
Jan 18, 2018 16:00 ET
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2017 Results
WARSAW, Ind., Jan. 18, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter and full-year sales and earnings conference call will be broadcast over the Internet on Tuesday, January 30, 2018, at 8 a.m. Eastern Time.  A news release detailing the quarterly and full-year results will be made available at 7 a.m. Eastern Time the morning of the conference call....
Jan 03, 2018 15:30 ET
Zimmer Biomet Announces FDA Clearance of the Sidus® Stem-Free Shoulder System
WARSAW, Ind., Jan. 3, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the Sidus® Stem-Free Shoulder system as a total shoulder arthroplasty solution for patients with good bone stock that have either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or who had previous surgeries of the shoulder that do not compromise the fixation. The Sidus Stem-Free Shoulder system is designed to anatomically restore ...
Jan 02, 2018 15:30 ET
Zimmer Biomet to Present at 36th Annual J.P. Morgan Healthcare Conference
WARSAW, Ind., Jan. 2, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 9, 2018 at 10 a.m. Pacific Time.  ...
Dec 22, 2017 15:30 ET
Zimmer Biomet Announces Publication of Positive Results from PROGRESS II Trial of Autologous Protein Solution Prepared with nSTRIDE® APS Kit in Treating Osteoarthritis of the Knee
WARSAW, Ind., Dec. 22, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the publication of positive results from a pilot study demonstrating the safety and promising efficacy of the nSTRIDE® Autologous Protein Solution (APS) Kit for the treatment of knee osteoarthritis (OA). In the trial, known as PROGRESS II, investigators prepared APS by using Zimmer Biomet's nSTRIDE APS Kit, which concentrates anti-inflammatory cytokines and growth factors from a sample of the patient's own blood, for delivery via a singl...
Dec 19, 2017 07:35 ET
Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer
WARSAW, Ind., Dec. 19, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Bryan C. Hanson has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective today.  Daniel P. Florin, who has served as Interim CEO since July 11, 2017, will continue in his role as Senior Vice President and Chief Financial Officer. ...
Dec 18, 2017 15:30 ET
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2017
WARSAW, Ind., Dec. 18, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2017....
Nov 21, 2017 16:00 ET
Zimmer Biomet to Present at 29th Annual Piper Jaffray Healthcare Conference
WARSAW, Ind., Nov. 21, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will participate in the 29th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel in New York City on November 28, 2017, at 4 p.m. EST. ...
Nov 14, 2017 07:40 ET
Report: Exploring Fundamental Drivers Behind CalAtlantic, EOG, Treehouse, Zimmer Biomet, NiSource, and Viavi – New Horizons, Emerging Trends, and Upcoming Developments
NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CalAtlantic Group, Inc. (NYSE:CAA), EOG Resources,...
Nov 08, 2017 17:00 ET
Zimmer Biomet to Present at Jefferies 2017 London Healthcare Conference
WARSAW, Ind., Nov. 8, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Jefferies 2017 London Healthcare Conference on November 16, 2017, at 11:20 a.m. GMT (6:20 a.m. ET). ...
Nov 01, 2017 08:00 ET
Zimmer Biomet Reports Third Quarter 2017 Financial Results
WARSAW, Ind., Nov. 1, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2017.  The Company reported third quarter net sales of $1.818 billion, a decrease of 0.8% from the prior year period, and a decrease of 1.2% on a constant currency basis.  Excluding approximately 30 basis points of contribution from the LDR Holding Corporation acquisition, third quarter 2017 revenues decreased 1.1% from the third quarter of 2016, or 1.5% on a constant currency basis....
Oct 25, 2017 08:30 ET
Zimmer Biomet Announces U.S. Launch of Vitality®+ and Vital™ Spinal Fixation Systems
WARSAW, Ind., Oct. 25, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the official launch of its Vitality®+ and Vital™ Spinal Fixation Systems in the United States at the 2017 North American Spine Society (NASS) Annual Meeting.   ...
Oct 10, 2017 08:30 ET
Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Third Quarter 2017 Results
WARSAW, Ind., Oct. 10, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter sales and earnings conference call will be broadcast over the Internet on Wednesday, November 1, 2017, at 8 a.m. Eastern Time. A news release detailing the quarterly results will be made available at 7 a.m. Eastern Time the morning of the conference call....
Oct 02, 2017 17:30 ET
Zimmer Biomet Announces U.S. Launch of Avenue® T TLIF Cage with Integrated VerteBRIDGE® Plating
WARSAW, Ind., Oct. 2, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it is officially launching in the United States the Avenue® T TLIF Cage. Avenue T advances posterior lumbar cage technology by incorporating VerteBRIDGE® plating, which facilitates simplified cage insertion and zero-profile, intradiscal fixation through a direct, minimally invasive surgical (MIS) approach. Avenue T is the first and only posteriorly implanted cage with integrated, anti-migration fixation, solidifying Zimmer Biomet as the f...
Sep 11, 2017 08:30 ET
Zimmer Biomet Announces Global Launch of the Persona® Partial Knee System
WARSAW, Ind., Sept. 11, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the launch of the Persona® Partial Knee System, the latest addition to its portfolio of personalized and anatomically designed knee implant systems. The launch of the Persona Partial Knee System is the first significant jointly developed new product for the Company since the Zimmer Biomet combination, and reinforces the Company's leadership position in partial knee replacement. ...
Sep 07, 2017 08:30 ET
Zimmer Biomet Holdings to Present at Morgan Stanley 15th Annual Global Healthcare Conference
WARSAW, Ind., Sept. 7, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Morgan Stanley 15th Annual Global Healthcare Conference at the Grand Hyatt hotel in New York.  Zimmer Biomet will present on Monday, September 11, 2017 at 11:40 a.m. Eastern Time....
Aug 07, 2017 18:00 ET
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2017
WARSAW, Ind., Aug. 7, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2017....
Jul 27, 2017 08:30 ET
Zimmer Biomet Reports Second Quarter 2017 Financial Results
WARSAW, Ind., July 27, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2017.  The Company reported second quarter net sales of $1.954 billion, an increase of 1.1% over the prior year period, and an increase of 2.1% on a constant currency basis.  Excluding approximately 240 basis points of contribution from the LDR Holding Corporation acquisition, second quarter 2017 revenues decreased 1.3% from the second quarter of 2016, or 0.3% on a constant currency basis....
Jul 11, 2017 17:31 ET
Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results
WARSAW, Ind., July 11, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it expects second quarter revenues to be approximately $1.954 billion, which would be an increase of 1.1% over the prior year period, and an increase of 2.1% on a constant currency basis. The Company had previously anticipated second quarter revenues in the range of $1.940 billion to $1.960 billion, with constant currency growth to be in the range of 2.4% to 3.4%. The Company estimates that foreign exchange rates had a favorable imp...
Jul 11, 2017 17:30 ET
Zimmer Biomet Announces Leadership Transition
WARSAW, Ind., July 11, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced that David C. Dvorak has stepped down as President and Chief Executive Officer and a member of the Board of Directors, effective today. To assist with the transition, Mr. Dvorak will serve in an advisory capacity to the Company for a period of time. The Board has appointed Daniel P. Florin, Senior Vice President and Chief Financial Officer, to serve in the additional role of Interim CEO and a member of the Board of Directors until a permanent ...
Jun 30, 2017 17:30 ET
Zimmer Biomet Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2017 Results
WARSAW, Ind., June 30, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter sales and earnings conference call will be broadcast live over the Internet on Thursday, July 27, 2017, at 8 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 7:30 a.m. Eastern Time the morning of the conference call....
Jun 28, 2017 17:30 ET
Zimmer Biomet Introduces the World's First CE Marked, X-Ray-Based Patient Specific Instrument System for Total Knee Replacement Surgery
WARSAW, Ind., June 28, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today introduced its X-ray-based Patient Specific Instrument, X-PSI™ Knee System, which is the world's first CE Marked surgical planning system that allows for patient specific implant positioning solely utilizing X-ray technology. X-PSI Knee System, for use with Zimmer Biomet's flagship total knee brands, allows surgeons to use X-ray images to generate three-dimensional anatomic models. Zimmer Biomet's Patient Specific Instruments Planner is then used ...
Jun 13, 2017 08:00 ET
Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility
WARSAW, Ind., June 13, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that the Warning Letter dated June 3, 2015 relating to its Zhejiang, China manufacturing facility has been closed out....
May 30, 2017 18:00 ET
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2017
WARSAW, Ind., May 30, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2017....
May 09, 2017 18:30 ET
Zimmer Biomet Named Top Workplace on Forbes' "America's Best Large Employers of 2017" List
WARSAW, Ind., May 9, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it has earned a spot on Forbes' "America's Best Large Employers of 2017" list. The Company was ranked among 500 U.S. employers as well as in the categories of Large Employers and Healthcare Equipment and Services....
May 08, 2017 08:30 ET
Zimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
WARSAW, Ind., May 8, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be presenting at the Bank of America Merrill Lynch 2017 Health Care Conference at the Encore at Wynn Las Vegas in Las Vegas, Nevada on Wednesday, May 17, 2017 at 8:40 a.m. Pacific Time. ...
Apr 27, 2017 08:30 ET
Zimmer Biomet Reports First Quarter 2017 Financial Results
WARSAW, Ind., April 27, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2017.  The Company reported first quarter net sales of $1.98 billion, an increase of 3.8% over the prior year period, and an increase of 4.5% on a constant currency basis.  Excluding approximately 220 basis points of contribution from the LDR Holding Corporation acquisition, revenue increased by 2.3% over the first quarter of 2016.  Diluted earnings per share for the quarter were $1.47 reported, an increase of 172.2% over the prior yea...
Apr 20, 2017 08:30 ET
Zimmer Biomet Holdings to Present at 42nd Annual Deutsche Bank Securities Annual Health Care Conference
WARSAW, Ind., April 20, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Deutsche Bank Securities 42nd Annual Health Care Conference at the InterContinental Hotel in Boston, Massachusetts on Wednesday, May 3, 2017.  Zimmer Biomet will present at 11:20 a.m. Eastern Time....
Apr 11, 2017 08:30 ET
Zimmer Biomet Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2017 Results
WARSAW, Ind., April 11, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter 2017 sales and earnings conference call will be broadcast live over the Internet on Thursday, April 27, 2017, at 8 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 7:30 a.m. Eastern Time the morning of the conference call....
Mar 14, 2017 17:30 ET
Zimmer Biomet Showcases New Product Innovation, Novel Digital Health Offering and Robotic Technology at AAOS 2017
WARSAW, Ind., March 14, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced plans to highlight its latest commercial offerings and preview its next generation of technological innovations at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting this week in San Diego, CA.  The Company's state-of-the-art booth (#4333) will feature an immersive and interactive tour of its newly launched digital technology and clinical services offering, Zimmer Biomet Signature Solutions, alongside more than 50 new pr...
Mar 01, 2017 07:00 ET
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2017
WARSAW, Ind., March 1, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2017....
Feb 24, 2017 16:30 ET
Zimmer Biomet Holdings to Present at the Cowen and Company 37th Annual Health Care Conference
WARSAW, Ind., Feb. 24, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will present at the Cowen and Company 37th Annual Health Care Conference at the Boston Marriott Copley Place on Tuesday, March 7, 2017 at 11:20 a.m. Eastern Time. ...
Feb 07, 2017 16:30 ET
Zimmer Biomet Announces the International Release of the Innovative Subchondroplasty® Procedure
WARSAW, Ind., Feb. 7, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the international release of the Subchondroplasty® (SCP®) Procedure.  The Company received CE Mark approval for the commercialization of its SCP Procedure to facilitate distribution in the European Union (EU) and other countries that recognize the CE Mark.  Zimmer Biomet also received approval for distribution in Canada, Singapore, Malaysia and Hong Kong. ...
Feb 07, 2017 07:30 ET
Zimmer Biomet Holdings to Present at the LEERINK Partners 6th Annual Global Healthcare Conference
WARSAW, Ind., Feb. 7, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will present at the LEERINK Partners 6th Annual Global Healthcare Conference at the Lotte New York Palace Hotel on Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ...
Feb 01, 2017 16:30 ET
Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
WARSAW, Ind., Feb. 1, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the U.S. Food and Drug Administration (FDA) approved an expanded 26-week efficacy claim for its single-injection viscosupplement Gel-One® Cross-linked Hyaluronate for the treatment of knee pain associated with osteoarthritis. Gel-One Cross-linked Hyaluronate may be administered in the physician office setting and is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequatel...
Jan 31, 2017 07:30 ET
Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
WARSAW, Ind., Jan. 31, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the fourth quarter and full year ended December 31, 2016.  The Company reported fourth quarter net sales of $2.013 billion, an increase of 4.1% over the prior year period, and an increase of 4.4% on an adjusted constant currency basis.  Excluding approximately 230 basis points of contribution from the LDR Holding Corporation transaction and adjusting for one less billing day in the quarter, revenues increased by 3.5% over the fourth quarter of 2015.  Diluted earni...
Jan 30, 2017 11:40 ET
Jan 24, 2017 19:52 ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Zimmer Biomet Holdings, Inc. - ZBH
NEW YORK, Jan. 24, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Zimmer Biomet Holdings, Inc. securities (NYSE: ZBH) from September 7, 2016 through October 31, 2016, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Zimmer Biomet investors under the federal securities laws....
Jan 17, 2017 17:00 ET
Zimmer Biomet Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2016 Results
WARSAW, Ind., Jan. 17, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter and full-year 2016 sales and earnings conference call will be broadcast live over the Internet on Tuesday, January 31, 2017, at 8 a.m. Eastern Time.  A news release detailing the quarterly and full-year results will be made available at 7:30 a.m. Eastern Time the morning of the conference call....
Jan 17, 2017 08:00 ET
Zimmer Biomet Announces Americas Leadership Transition
WARSAW, Ind., Jan. 17, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it has implemented a leadership transition that capitalizes on the strength of the Zimmer Biomet management team. Effective January 23, 2017, Robert D. Delp will assume the position of President, Americas and join the executive leadership team of the Company. Mr. Delp previously served as Zimmer Biomet's Vice President of U.S. Sales, leading sales for the Knee, Hip, Bone Cement, Biologics, Extremities, Sports Medicine, Foot and Ankl...
Jan 14, 2017 11:02 ET
DEADLINE (ZBH) ALERT: Johnson & Weaver, LLP Reminds Investors of Class Action Against Zimmer Biomet Holdings, Inc. (ZBH) and January 31, 2017 Lead Plaintiff Deadline
SAN DIEGO, Jan. 14, 2017 /PRNewswire/ -- Johnson & Weaver, LLP announces that a class action complaint was filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ZBH)  securities during the period between September 7, 2016, through October 31, 2016 (the "Class Period")....
Jan 13, 2017 11:09 ET
ZBH INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Zimmer Biomet Holdings, Inc. and a Lead Plaintiff Deadline of January 31, 2017
NEW YORK, Jan. 13, 2017 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of Indiana on behalf of investors who purchased Zimmer Biomet Holdings, Inc. (NYSE: ZBH) securities between September 7, 2016 and October 31, 2016....
Jan 12, 2017 12:30 ET
Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
WARSAW, Ind., Jan. 12, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has concluded agreements with the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) to resolve the previously disclosed U.S. Foreign Corrupt Practices Act (FCPA) matters involving Biomet, Inc., as well as in relation to the former deferred prosecution agreement and consent to final judgment that Biomet entered into with DOJ and SEC, respectively, on March 26, 2012.  All of the Biomet condu...
Jan 11, 2017 16:35 ET
ZBH NOTICE: Rosen Law Firm Reminds Zimmer Biomet Holdings, Inc. Investors of Important Deadline in Class Action – ZBH
NEW YORK, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Zimmer Biomet Holdings, Inc. securities (NYSE:ZBH) from September 7, 2016 through October 31, 2016, inclusive (the “Class Period”) of the important January 31, 2017 lead plaintiff deadline. The lawsuit seeks to recover damages for Zimmer Biomet investors under the federal securities laws....
Jan 10, 2017 07:30 ET
Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
WARSAW, Ind., Jan. 10, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced preliminary financial results for the fourth quarter and full year ended December 31, 2016....
Jan 03, 2017 08:00 ET
Zimmer Biomet Holdings to Present at 35th Annual J.P. Morgan Healthcare Conference
WARSAW, Ind., Jan. 3, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, has announced that it will present at the 35th Annual J.P. Morgan Healthcare Conference, at the Westin St. Francis Hotel in San Francisco, California, on Tuesday, January 10, 2017, at 8:30 a.m. Pacific Standard Time....
Dec 28, 2016 15:11 ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Zimmer Biomet Holdings, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In
STEVENSON, Md., Dec. 28, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Indiana on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) (“Zimmer” or the “Company”) securities during the period between September 7, 2016 and October 31, 2016, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until January 31, 2017 to seek appointment as lead plainti...
Dec 28, 2016 10:41 ET
ZBH INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Zimmer Biomet Holdings, Inc. and a Lead Plaintiff Deadline of January 31, 2017
NEW YORK, Dec. 28, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of Indiana on behalf of investors who purchased Zimmer Biomet Holdings, Inc. (NYSE:ZBH) securities between September 7, 2016 and October 31, 2016....
Dec 27, 2016 14:46 ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Zimmer Biomet Holdings, Inc. – ZBH
NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Zimmer Biomet Holdings, Inc. securities (NYSE:ZBH) from September 7, 2016 through October 31, 2016, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Zimmer Biomet investors under the federal securities laws....
Dec 14, 2016 16:30 ET
National Joint Registry Analysis Finds Zimmer Biomet Trabecular Metal™ Cups Associated with Significantly Lower Risk of Subsequent Revision Due to Infection in Revision Hip Procedures
WARSAW, Ind., Dec. 14, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced positive outcomes associated with the use of its Trabecular Metal™ Cups in more than 9,500 patients undergoing revision hip arthroplasty.  The data, which stemmed from a new report by the National Joint Registry (NJR) for England, Wales, Northern Ireland and the Isle of Man, documented that Trabecular Metal Cups were associated with lower infection rates and a significant reduction in subsequent hip revision rates. ...
Dec 13, 2016 17:00 ET
Zimmer Biomet Strengthens Spine Offering with PrimaGen Advanced™ Allograft
WARSAW, Ind., Dec. 13, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the launch of PrimaGen Advanced Allograft, an autograft substitute containing the same bone healing elements as autograft, but without the risks associated with donor site morbidity or harvest site complications.  Allograft is human tissue transplanted from a donor to a patient, while autograft tissue is transferred from one part of a patient's body to another.  PrimaGen Advanced Allograft offers a combination of demineralized cortical b...
Dec 13, 2016 16:30 ET
Zimmer Biomet Announces Closing of €1 Billion Senior Notes Offering and Early Settlement of Its Cash Tender Offers for Certain Outstanding Debt Securities
WARSAW, Ind., Dec. 13, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced that it has completed an offering of €500 million aggregate principal amount of 1.414% Notes due 2022 (the "2022 Notes") and €500 million aggregate principal amount of 2.425% Notes due 2026 (together with the 2022 Notes, the "Euro Notes") in an SEC registered offering. The Company used the net proceeds from the sale of the Euro Notes to pay for the debt securities identified in the table below (collectively, the "Tender Offer Notes") purchased in its previously-announc...
Dec 13, 2016 09:44 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zimmer Biomet Holdings, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 31, 2017 -- ZBH
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) between September 7, 2016 and October 31, 2016. You are...
Dec 09, 2016 13:34 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc.
NEW YORK, Dec. 9, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) ("Zimmer Biomet" or the "Company").  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980....
Dec 08, 2016 10:10 ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Zimmer Biomet Holdings, Inc. (ZBH) and Lead Plaintiff Deadline: January 31, 2017
NEW YORK, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE:ZBH) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Zimmer securities between September 7, 2016 and October 31, 2016, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/zbh....
Dec 07, 2016 22:00 ET
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Zimmer Biomet Holdings, Inc. To Contact Brower
STEVENSON, Md., Dec. 07, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Indiana on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) (“Zimmer” or the “Company”) securities during the period between September 7, 2016 and October 31, 2016, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until January 31, 2017 to seek appointment as lead plainti...
Dec 06, 2016 18:54 ET
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Zimmer Biomet Holdings, Inc. To Contact The Firm Before Lead Plaintiff Deadline
NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE:ZBH) of the January 31, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers....
Dec 06, 2016 14:06 ET
Dec 06, 2016 13:50 ET
Zimmer Biomet Prices Offering of Euro-Denominated Senior Notes
WARSAW, Ind., Dec. 6, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced that it has priced an offering of €500.0 million principal amount of its 1.414% senior unsecured notes due 2022 and €500.0 million principal amount of its 2.425% senior unsecured notes due 2026. ...
Dec 06, 2016 13:10 ET
Zimmer Biomet Announces the Pricing Terms of Its Cash Tender Offers for Certain Outstanding Debt Securities
WARSAW, Ind., Dec. 6, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced the pricing terms of its previously‑announced cash tender offers (the "Offers") for up to $1.25 billion aggregate purchase price (excluding accrued and unpaid interest to, but not including, the applicable settlement date and excluding fees and expenses related to the Offers) (the "Maximum Tender Amount") of the debt securities identified in the table below (collectively, the "Notes"). The terms and conditions of the Offers are described in the Offer to Purchase dated N...
Dec 05, 2016 20:10 ET
Zimmer Biomet Announces the Early Tender Results and Upsizing of Its Cash Tender Offers for Certain Outstanding Debt Securities
WARSAW, Ind., Dec. 5, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced that, pursuant to its previously‑announced cash tender offers (the "Offers") for the debt securities identified in the table below (collectively, the "Notes"), approximately $2.6 billion in aggregate principal amount of Notes were validly tendered and not validly withdrawn on or prior to 5:00 p.m., New York City time, today, December 5, 2016 (the "Early Tender Deadline"). The Company also announced that it is increasing the aggregate purchase price (excluding accrued an...
Dec 05, 2016 14:15 ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Zimmer Biomet Holdings, Inc. (ZBH) and Lead Plaintiff Deadline: January 31, 2017
NEW YORK, Dec. 5, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zimmer Biomet Holdings, Inc. ("Zimmer" or the "Company") (NYSE: ZBH) and certain of its officers, and is on behalf of shareholders who purchased or otherwise acquired Zimmer securities between September 7, 2016 and October 31, 2016, both dates inclusive (the "Class Period"). Such investors are advised to join this case by visiting the firm's site: http://www.bgandg.com/zbh. ...
Dec 03, 2016 09:22 ET
ZIMMER BIOMET (ZBH) ALERT: Johnson & Weaver, LLP Announces Filing of Class Action Complaint Against Zimmer Biomet Holdings, Inc.; Encourages all Investors to Contact the Firm for Information
SAN DIEGO, Dec. 3, 2016 /PRNewswire/ -- Johnson & Weaver, LLP announces that a class action complaint was filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ZBH)  securities during the period between September 7, 2016 through October 31, 2016 (the "Class Period")....
Nov 22, 2016 16:30 ET
Zimmer Biomet Named Indo UK Institutes of Health Medicities Program's Preferred Orthopaedic Partner to Improve Delivery of Care in India
WARSAW, Ind., Nov. 22, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the Company has been chosen as an Indo UK Institutes of Health (IUIH) preferred orthopaedic partner to improve the delivery of and access to quality, affordable musculoskeletal healthcare for approximately 400 million people in India over the next 20 years through IUIH's 11 centers of excellence ("Medicities") to be created in major states across the country.  IUIH Medicities will offer patients throughout India and abroad access to...
Nov 21, 2016 09:17 ET
Zimmer Biomet Announces Cash Tender Offers for Up to $1.1 Billion Aggregate Purchase Price of Certain Outstanding Debt Securities
WARSAW, Ind., Nov. 21, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") today announced the commencement of cash tender offers (collectively, the "Offers") for up to $1.1 billion aggregate purchase price (excluding accrued and unpaid interest to, but not including, the applicable settlement date and excluding fees and expenses related to the Offers) (the "Maximum Tender Amount") of its 5.750% Senior Notes due 2039, its 4.450% Senior Notes due 2045, its 4.250% Senior Notes due 2035, its 3.550% Senior Notes due 2025 and its 4.625% Senior Notes due 2019 (col...
Nov 17, 2016 16:30 ET
Zimmer Biomet Announces Launch of the Comprehensive® Vault Reconstruction System - the First Commercially Available Patient-matched Glenoid Implant
WARSAW, Ind., Nov. 17, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the launch of the Comprehensive® Vault Reconstruction System (VRS), the first patient-matched glenoid implant cleared to specifically treat patients with a severely deficient rotator cuff and extensive bone loss which precludes the use of a standard glenoid baseplate. The VRS uses CT imaging and advanced 3D reconstruction techniques to allow surgeons to personalize each patient's implant. ...
Nov 15, 2016 08:00 ET
Zimmer Biomet Reports Positive Update on Biologics Pipeline Following a Preliminary Analysis of Data from the First Pivotal Trial of Stem Cell Therapy for Critical Limb Ischemia to Reach Completion
WARSAW, Ind., Nov. 15, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced an update on its Investigational Device Exemption (IDE) clinical trial evaluating the use of autologous concentrated bone marrow aspirate (cBMA), prepared via the MarrowStim™ PAD Kit, for the treatment of critical limb ischemia (CLI). The trial, known as MOBILE (MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa in Subjects with Severe Peripheral ArteriaL DiseasE), is the first pivotal study of its kind to complete enrollmen...
Nov 04, 2016 10:51 ET
Johnson & Weaver, LLP Initiates Investigations of TreeHouse Foods, Inc., Zimmer Biomet Holdings, Inc., AAC Holdings, Inc. and Big Lots Inc.
SAN DIEGO, Nov. 4, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP, is investigating potential claims against TreeHouse Foods, Inc., Zimmer Biomet Holdings, Inc., AAC Holdings, Inc. and Big Lots Inc., as detailed below:...
Nov 02, 2016 07:39 ET
ZIMMER BIOMET (ZBH) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Zimmer Biomet Holdings, Inc.; Investors Encouraged to Contact Firm
SAN DIEGO, Nov. 2, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP has commenced an investigation of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) concerning possible violations of federal securities laws. Zimmer provides musculoskeletal healthcare products and solutions. ...
Nov 01, 2016 16:26 ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Zimmer Biomet Holdings, Inc. (ZBH)
NEW YORK, Nov. 1, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities Zimmer Biomet Holdings, Inc. ("Zimmer" or the "Company") (NYSE: ZBH). Such investors are advised to contact Peretz Bronstein or his investor relations analyst Yael Hurwitz at info@bgandg.com or 212-697-6484.  ...
Oct 31, 2016 08:30 ET
Zimmer Biomet Reports Third Quarter 2016 Financial Results
WARSAW, Ind., Oct. 31, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2016.  The Company reported third quarter net sales of $1.83 billion, an increase of 4.0% compared to the third quarter of 2015.  On an adjusted constant currency basis, revenue increased 3.5% over the prior year period, with the recently acquired LDR Holding Corporation contributing 190 basis points.  Diluted earnings per share for the quarter were $0.78, an increase of 609.1% over the prior year period, and adjusted diluted earnin...
Oct 27, 2016 08:30 ET
Zimmer Biomet Acquires RespondWell® Telerehabilitation Platform for Zimmer Biomet Signature Solutions
WARSAW, Ind., Oct. 27, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the acquisition of RespondWell®, an award-winning telerehabilitation technology designed to provide personalized, clinician-supervised post-surgical physical therapy in the comfort of a patient's home. The acquisition strengthens the Company's recently announced Zimmer Biomet Signature Solutions commercial offering by integrating a comprehensive, at-home telerehabilitation capability designed to enhance patient compliance with physical t...
Oct 26, 2016 18:07 ET
Zimmer Biomet Announces Positive Comparative Data from 7-Year Follow-Up Study of Mobi-C® Cervical Disc Prosthesis for Cervical Disc Replacement
WARSAW, Ind., Oct. 26, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced results of a seven-year outcomes study demonstrating statistical superiority of its Mobi-C® Cervical Disc Prosthesis versus two-level anterior cervical discectomy and fusion (ACDF) in overall success. In the study, overall success required improvement in Neck Disability Index (NDI), no secondary surgical interventions at the index levels, and absence of major complications defined as radiographic failure, neurological failure or adverse ...
Oct 25, 2016 17:30 ET
Zimmer Biomet's Mobi-C® Cervical Disc Becomes Most Widely Covered Intervertebral Disc Prosthesis for Cervical Disc Replacement
WARSAW, Ind., Oct. 25, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Mobi-C® Cervical Disc Prosthesis is now the most widely covered device for one- and two-level cervical disc replacement by commercial health insurers in the United States.  Mobi-C, acquired as part of Zimmer Biomet's combination with LDR Holding Corporation in July, is now accessible to more than 200 million insured patients with one-level disc disease and more than 150 million patients with two-level disc disease across more th...
Oct 20, 2016 17:30 ET
Zimmer Biomet Expands Foot and Ankle Portfolio Through Exclusive Global Distribution Agreement with Nextremity Solutions, Inc.
WARSAW, Ind., Oct. 20, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced an exclusive agreement with Nextremity Solutions, Inc. to globally distribute the company's foot and ankle deformity correction products. The financial terms of the transaction were not disclosed. ...
Oct 06, 2016 18:00 ET
Zimmer Biomet Announces Live Audio Webcast and Conference Call of Third Quarter 2016 Results
WARSAW, Ind., Oct. 6, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter 2016 sales and earnings conference call will be broadcast live over the Internet on Monday, October 31, 2016, at 8 a.m. Eastern Time. A news release detailing the quarterly results will be made available at 7:30 a.m. Eastern Time the morning of the conference call....
Sep 22, 2016 08:00 ET
Zimmer Biomet Contributes Additional $100,000 in Funding to the Orthopaedic Research and Education Foundation
ROSEMONT, Ill. and WARSAW, Ind., Sept. 22, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today pledged to donate up to $100,000 in matching funds to the Orthopaedic Research and Education Foundation (OREF).  According to the agreement, Zimmer Biomet will help underwrite OREF's grant administration costs by donating 10 cents for every dollar given to OREF by individual donors. ...
Sep 20, 2016 08:00 ET
Zimmer Biomet Launches VANGUARD® Individualized Design Knee Replacement
WARSAW, Ind., Sept. 20, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the launch of Vanguard® Individualized Design (ID), a first-of-its-kind total knee arthroplasty (TKA) construct designed to enable a personalized fit while simplifying soft tissue preservation and balance. Traditional total knee implants feature a one-piece bearing constructed of polyethylene which is placed between the metal portions of the implant. Vanguard ID is the only TKA design to incorporate two individual polyethylene bearings ...
Sep 15, 2016 08:00 ET
Zimmer Biomet Adds 3D Range-of-Motion Simulation Capability with Strategic Acquisition of Clinical Graphics
WARSAW, Ind., Sept. 15, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, recently announced the strategic acquisition of Clinical Graphics, B.V., a novel imaging company specializing in 3D range-of-motion simulation technology to inform treatment decisions for common hip conditions requiring early intervention. Zimmer Biomet plans to integrate the new imaging platform to enhance its hip preservation portfolio....
Sep 07, 2016 08:00 ET
Zimmer Biomet Earns EPA Recognition for Converting Warsaw-Indiana Headquarters to 100-Percent Green Power
WARSAW, Ind., Sept. 7, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Warsaw, Indiana-based headquarters will be wholly powered by renewable, green energy, in compliance with the U.S. Environmental Protection Agency's (EPA) Green Power Partnership program. Green power is zero-emissions electricity that is generated from environmentally preferable renewable resources, such as wind, solar, geothermal, biogas, eligible biomass, and low-impact hydro. Zimmer Biomet's headquarters building will receive ...
Sep 01, 2016 17:30 ET
Zimmer Biomet Holdings to Present at INVESTIndiana Equity Conference
WARSAW, Ind., Sept. 1, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced that it will be participating in the INVESTIndiana Equity Conference at the Indianapolis Marriott Downtown on Thursday, September 15, 2016 at 1:10 p.m. Eastern Time....
Aug 23, 2016 08:30 ET
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2016
WARSAW, Ind., Aug. 23, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2016. ...
Aug 18, 2016 18:00 ET
Zimmer Biomet Holdings to Present at Morgan Stanley 2016 Global Healthcare Conference
WARSAW, Ind., Aug. 18, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced that it will be participating in the Morgan Stanley 2016 Global Healthcare Conference at the Grand Hyatt hotel in New York.  Zimmer Biomet will present on Monday, September 12, 2016 at 9:20 a.m. Eastern Time....
Aug 17, 2016 08:30 ET
Health sciences and economic leader David Johnson to address INVESTIndiana Equity Conference
INDIANAPOLIS, Aug. 17, 2016 (GLOBE NEWSWIRE) -- An Indiana leader who raises millions of dollars of seed money, directs a strategic partnership of CEOs, university presidents and other business VIPs, and is a prominent face of the Indiana Economic Club will be the keynote speaker at the Sept. 15 INVESTIndiana Equity Conference....
Aug 16, 2016 18:00 ET
Zimmer Biomet to Present at 11th Annual Wells Fargo Securities Healthcare Conference
WARSAW, Ind., Aug. 16, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the 11th Annual Wells Fargo Securities Healthcare Conference at the Westin Boston Waterfront hotel in Boston, Massachusetts.  Zimmer Biomet will present on Wednesday, September 7, 2016 at 9:55 a.m. Eastern Time. ...
Aug 15, 2016 09:03 ET
Zimmer Biomet Strengthens Musculoskeletal Diagnostic Offering with Acquisition of CD Diagnostics
WARSAW, Ind., Aug. 15, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the acquisition of CD Diagnostics, a fully-integrated, Delaware-based diagnostics company focused on developing immunoassays and biomarker testing to inform treatment decisions that improve patient outcomes. The financial terms of the transaction were not disclosed....
Aug 10, 2016 09:19 ET
Zimmer Biomet Holdings Announces Pricing of Secondary Offering of Common Stock
WARSAW, Ind., Aug. 10, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced the pricing of the previously announced underwritten secondary offering of 7,440,675 shares of its common stock by certain of its stockholders, consisting of affiliates of KKR and TPG.  The shares are being sold to the public at an initial price of $129.75 per share. The selling stockholders will receive all of the proceeds of the offering.  Neither Zimmer Biomet nor any of its directors, officers or other stockholders is selling any shares of common stock in the offering. The closing...
Aug 09, 2016 17:08 ET
Zimmer Biomet Holdings Announces Launch of Secondary Offering of Common Stock
WARSAW, Ind., Aug. 9, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that certain of its stockholders, consisting of affiliates of KKR and TPG, intend to offer for sale in an underwritten secondary offering 7,440,675 shares of the common stock of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet").  The selling stockholders will receive all of the proceeds of the offering.  Neither Zimmer Biomet nor any of its directors, officers or other stockholders is offering shares of common stock in the offering....
Jul 28, 2016 08:30 ET
Zimmer Biomet Reports Second Quarter 2016 Financial Results
WARSAW, Ind., July 28, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2016.  The Company reported second quarter net sales of $1.93 billion, an increase of 65.6% and an increase of 4.5% on an adjusted pro forma, constant currency basis, compared to the second quarter of 2015.  Diluted net loss per share for the quarter was $(0.16), compared to a net loss per share of $(1.00) for the prior year period, and adjusted diluted earnings per share for the quarter were $2.02, an increase of 27.8% adjusted over the...
Jul 26, 2016 07:30 ET
Zimmer Biomet Unveils Signature Solutions™
WARSAW, Ind., July 26, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today unveiled Signature Solutions™, a comprehensive suite of clinical services and technologies designed to assist hospitals and medical practices to seamlessly transition to value-based healthcare models by maintaining excellent patient outcomes, while maximizing procedural and cost efficiencies across the entire episode of care.  Last year alone, the U.S. launched two major value-based healthcare mandates, the Comprehensive Care for Joint Replacement...
Jul 20, 2016 08:00 ET
Zimmer Biomet Announces Multi-Year Collaboration with Indo UK Institutes of Health to Deliver Affordable and Accessible Healthcare in India
WARSAW, Ind., July 20, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a multi-year collaboration with the Indo UK Institutes of Health (IUIH) that will increase the capacity of India's healthcare infrastructure.  The first phase of the collaboration involves the establishment of the Zimmer Biomet Institute of India, a 30,000 square foot state-of-the-art medical training and education facility on the campus of King's College Hospital in Amaravati, Andhra Pradesh.  The Institute will help improve the deliver...
Jul 13, 2016 08:00 ET
Zimmer Biomet Completes Tender Offer for Outstanding Shares of LDR Holding Corporation
WARSAW, Ind., July 13, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet) today announced that it has successfully completed its offer to purchase all outstanding shares of the common stock of LDR Holding Corporation (NASDAQ: LDRH) (LDR) for $37.00 per share, net to the seller in cash, without interest, less any deductions or withholding of taxes required by applicable law....
Jul 11, 2016 17:01 ET
Zimmer Biomet Announces Live Audio Webcast and Conference Call of Second Quarter 2016 Results
WARSAW, Ind., July 11, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter 2016 sales and earnings conference call will be broadcast live over the Internet on Thursday, July 28, 2016, at 8 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 7:30 a.m. Eastern Time the morning of the conference call....
Jun 27, 2016 17:30 ET
Zimmer Biomet Celebrates Four Decades of Excellence with the 40th Anniversary of the Oxford® Partial Knee System
WARSAW, Ind., June 27, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the 40th anniversary of the Oxford® Partial Knee System, the most widely used and clinically proven1 partial knee replacement system in the world.  A partial knee replacement is a treatment for osteoarthritis (OA) in which one of the knee's three compartments is replaced, whereas with total knee replacement, all three of the knee's compartments are replaced. Studies have shown partial knee replacement patients have better range of...
Jun 27, 2016 09:00 ET
Zimmer Biomet Announces Early Termination of HSR Waiting Period
WARSAW, Ind., June 27, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ("Zimmer Biomet") today announced the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for its offer to purchase all outstanding shares of common stock of LDR Holding Corporation (NASDAQ: LDRH) ("LDR")....
Jun 16, 2016 17:30 ET
Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
WARSAW, Ind., June 16, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the global commercial launch of new enhancements to its OSS™ Orthopedic Salvage System, a comprehensive set of joint reconstruction prostheses designed to treat patients suffering from bone loss due to tumor resection, ligamentous deficiencies, orthopaedic trauma or patients who have undergone multiple knee and hip revision arthroplasties. ...
Jun 14, 2016 07:18 ET
Zimmer Biomet Holdings Announces Pricing of Secondary Offering of Common Stock
WARSAW, Ind., June 14, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced the pricing of the previously announced underwritten secondary offering of 11,116,533 shares of its common stock by certain of its stockholders, consisting of affiliates of KKR, Goldman Sachs and TPG.  The shares are being sold to the public at an initial price of $115.85 per share. The selling stockholders will receive all of the proceeds of the offering.  Neither Zimmer Biomet nor any of its directors, officers or other stockholders is selling any shares of common stock in the offer...
Jun 13, 2016 17:54 ET
Zimmer Biomet Holdings Announces Launch of Secondary Offering of Common Stock
WARSAW, Ind., June 13, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that certain of its stockholders, consisting of affiliates of KKR, Goldman Sachs and TPG, intend to offer for sale in an underwritten secondary offering 11,116,533 shares of the common stock of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet").  The selling stockholders will receive all of the proceeds of the offering.  Neither Zimmer Biomet nor any of its directors, officers or other stockholders is offering shares of common stock in the offering....
Jun 09, 2016 12:20 ET
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
NEW YORK, June 9, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:...
Jun 08, 2016 21:14 ET
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price?
SAN DIEGO, June 8, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH)....
Jun 07, 2016 09:13 ET
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Are Shareholders Getting a Fair Price?
SAN DIEGO, June 7, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH)....
Jun 07, 2016 08:00 ET
Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
WARSAW, Ind. and AUSTIN, Texas, June 7, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ: LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares o...
Jun 07, 2016 07:04 ET
Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business
Significantly Expands Portfolio of Innovative Solutions for $10 Billion Spine MarketPositions Company to Capitalize on Faster Growing Spine Segments, including Cervical Disc ReplacementCompanies to Host Conference Call at 8:00 AM ET WARSAW, Ind. and AUSTIN, Texas, June 07, 2016 (GLOBE NEWSWIRE) -- Zimmer Biomet Holdings, Inc. (NYSE:ZBH) (SIX:ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ:LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies ...
May 23, 2016 08:30 ET
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016
WARSAW, Ind., May 23, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2016. ...
May 16, 2016 08:30 ET
Zimmer Biomet Completes Acquisition of Cayenne Medical
WARSAW, Ind., May 16, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the completion of its previously announced acquisition of Scottsdale, Arizona-based Cayenne Medical, Inc.  Cayenne Medical designs, develops and markets technically advanced soft tissue repair and reconstruction solutions for the knee, shoulder and extremities....
May 03, 2016 17:01 ET
Zimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
WARSAW, Ind., May 3, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be presenting at the Bank of America Merrill Lynch 2016 Health Care Conference at the Encore Wynn hotel in Las Vegas, Nevada on Wednesday, May 11, at 8 a.m. Pacific Time....
Apr 28, 2016 08:30 ET
Apr 26, 2016 10:00 ET
Zimmer Biomet Holdings to Present at Deutsche Bank Securities Annual Health Care Conference
WARSAW, Ind., April 26, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Deutsche Bank Securities 41st Annual Health Care Conference at the InterContinental Hotel in Boston, Massachusetts on May 5, 2016.  Zimmer Biomet will present at 12:50 p.m. Eastern Time....
Apr 25, 2016 10:15 ET
Zimmer Biomet Enters into Definitive Agreement to Acquire Cayenne Medical
WARSAW, Ind., April 25, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has entered into a definitive agreement to acquire Scottsdale, Arizona-based Cayenne Medical, Inc. The transaction, which is subject to customary closing conditions, is expected to close during the second quarter of 2016. The financial terms of the transaction were not disclosed.  ...
Apr 14, 2016 10:15 ET
Zimmer Biomet Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2016 Results
WARSAW, Ind., April 14, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter 2016 sales and earnings conference call will be broadcast live over the Internet on Thursday, April 28, 2016, at 8 a.m. Eastern Time.  A news release detailing the quarterly results will be made available at 7:30 a.m. Eastern Time the morning of the conference call....
Mar 04, 2016 09:00 ET
Zimmer Biomet Secures Exclusive Global Distribution Agreement with CelgenTek Innovations Corporation
WARSAW, Ind., March 4, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, has announced that it has secured an exclusive global distribution agreement with CelgenTek Innovations Corporation, which includes its N-Force Fixation System® and iN3 Cement.  This innovative bone void-filling solution allows healthcare professionals to directly administer Zimmer Biomet's N-Force Blue­­­­­­–Bone Substitute Material (BSM) (available in the United States) and CelgenTek's iN3 Cement (available in the European Union) directly through a fe...
Mar 03, 2016 16:16 ET
Zimmer Biomet Announces the Release of New Implant Technologies in Support of the Persona Knee System and Vanguard 360 Revision Knee System
WARSAW, Ind., March 3, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the commercial launch of the Persona Medial Congruent Bearing and OsseoTi Tibial Sleeves for the Vanguard 360 Revision Knee System.  These enhancements to Zimmer Biomet's Knee portfolio represent the expansion of two of the Company's flagship knee systems, and combine anatomically inspired designs with cutting-edge advances in implant engineering....
Mar 03, 2016 09:00 ET
Zimmer Biomet Announces FDA Clearance for Compatibility of Nexel™ Total Elbow and Comprehensive® Segmental Revision System
WARSAW, Ind., March 3, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the compatibility of the Nexel™ Total Elbow System with the Comprehensive® Segmental Revision System (SRS).  This 510(k) clearance marks the first submission by the Company to establish the compatibility of two separate Zimmer Biomet implant systems.  The distal component of the Comprehensive SRS humeral system when combined with th...
Mar 02, 2016 09:00 ET
Zimmer Biomet Announces Commercial Launch of the Echo® Bi-Metric® Microplasty® Stem, G7® Dual Mobility Construct and Arcos® One-Piece Revision System
WARSAW, Ind., March 2, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the commercial launch of three new Hip portfolio offerings, innovatively designed to address a broad range of clinical indications, patient anatomy and surgical techniques.  These enhancements to three successful Zimmer Biomet Hip systems combine clinical heritage with new advances in implant design and musculoskeletal treatment....
Mar 01, 2016 17:14 ET
Zimmer Biomet Acquires Ortho Transmission, LLC and Assets for Pioneering Technology to Restore Limb Amputee Patients
WARSAW, Ind., March 1, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has completed the acquisition of Colorado-based Ortho Transmission, LLC.  The acquisition includes Ortho Transmission's transcutaneous osseous integrated skeletal implant technology, which complements Zimmer Biomet's ongoing collaboration with the U.S. Department of Defense for the development of a transcutaneous system for anchoring external prosthetic limbs, in order to restore the mobility of amputee patients.  The financial t...
Feb 25, 2016 16:16 ET
Zimmer Biomet Holdings to Present at Barclays Global Healthcare Conference
WARSAW, Ind., Feb. 25, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced that it will be participating in the Barclays Global Healthcare Conference at the Loews Miami Beach hotel in Miami Beach, Florida on Wednesday, March 16, 2016.  Zimmer Biomet will present at 9:00 a.m. Eastern Time.  ...
Feb 24, 2016 16:16 ET
Zimmer Biomet Announces 9.1% Increase in Quarterly Dividend for First Quarter of 2016 and New Share Repurchase Authorization
WARSAW, Ind., Feb. 24, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2016.  The new payment represents an increase of 9.1 percent over the dividend declared for the first quarter of 2015.  Additionally, Zimmer Biomet's Board of Directors has authorized a new share repurchase program.   ...
Feb 11, 2016 16:16 ET
Zimmer Biomet Announces FDA Clearance for Unite3D™ Bridge Fixation System
WARSAW, Ind., Feb. 11, 2016 /PRNewswire/ -- Zimmer Biomet Holdings (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce that the Company has received 510(k) clearance from the U.S. Food and Drug Administration for the Unite3D™ Bridge Fixation System, a groundbreaking 3D-printed technology designed to offer stability in foot and ankle arthrodesis (joint fusion) surgery. Featuring Zimmer Biomet's proprietary OsseoTi® porous metal technology, which mimics the architecture of cancellous bone, the Unite3D Bridge Fixation System includes an osteoconductive mat...
Feb 05, 2016 06:01 ET
Zimmer Biomet Holdings Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
WARSAW, Ind., Feb. 5, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced the pricing of the previously announced underwritten secondary offering of 11,027,558 shares of its common stock by certain of its stockholders, consisting of affiliates of Blackstone and Goldman Sachs.  The shares are being sold to the public at an initial price of $96.45 per share. The selling stockholders will receive all of the proceeds of the offering.  Neither Zimmer Biomet nor any of its directors, officers or other stockholders is selling any shares of common stock in the offer...
Feb 04, 2016 16:55 ET
Zimmer Biomet Holdings Announces Launch of Secondary Offering of Common Stock and Concurrent Share Repurchase from Selling Stockholders
WARSAW, Ind., Feb. 4, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that certain of its stockholders, consisting of affiliates of Blackstone and Goldman Sachs, intend to offer for sale in an underwritten secondary offering 11,027,558 shares of the common stock of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet").  The selling stockholders will receive all of the proceeds of the offering.  Neither Zimmer Biomet nor any of its directors, officers or other stockholders is offering shares of common stock in the offering....
Jan 28, 2016 07:30 ET